Jenna Bollyky, MD

Jenna Bollyky, MD

Stanford University

H-index: 21

North America-United States

About Jenna Bollyky, MD

Jenna Bollyky, MD, With an exceptional h-index of 21 and a recent h-index of 17 (since 2020), a distinguished researcher at Stanford University, specializes in the field of Type 1 diabetes, clinical trials, bioinformatics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Adjusting Incidence Estimates with Laboratory Test Performances: A Pragmatic Maximum Likelihood Estimation-Based Approach

Autoantibody Profiles Differ in Immunocompromised Hospitalized COVID-19 Patients, But Are Not Associated With Mortality

MAJOR ARTICLE

Association of protective behaviors with SARS-CoV-2 infection: results from a longitudinal cohort study of adults in the San Francisco Bay Area

Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double …

A Selective Leukotriene B4 Antagonist, Acebilustat, for Treatment of Outpatients With COVID-19 Disease: A Randomized, Double-blind, Placebo-controlled Phase 2 Trial

Oral hymecromone decreases hyaluronan in human study participants

Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area

Jenna Bollyky, MD Information

University

Position

___

Citations(all)

2900

Citations(since 2020)

1369

Cited By

2058

hIndex(all)

21

hIndex(since 2020)

17

i10Index(all)

28

i10Index(since 2020)

23

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Jenna Bollyky, MD Skills & Research Interests

Type 1 diabetes

clinical trials

bioinformatics

Top articles of Jenna Bollyky, MD

Title

Journal

Author(s)

Publication Date

Adjusting Incidence Estimates with Laboratory Test Performances: A Pragmatic Maximum Likelihood Estimation-Based Approach

Epidemiology

Yingjie Weng

Lu Tian

Derek Boothroyd

Justin Lee

Kenny Zhang

...

2024/5/1

Autoantibody Profiles Differ in Immunocompromised Hospitalized COVID-19 Patients, But Are Not Associated With Mortality

HD Morin

AE Pacheco-Navarro

E Yang

E Caldwell

BT Thompson

...

2023/5

MAJOR ARTICLE

Joseph E Levitt

Haley Hedlin

Sophie Duong

Di Lu

Justin Lee

...

2023

Association of protective behaviors with SARS-CoV-2 infection: results from a longitudinal cohort study of adults in the San Francisco Bay Area

Annals of Epidemiology

Timothy J Judson

Shiqi Zhang

Christina P Lindan

Derek Boothroyd

Kevin Grumbach

...

2023/10/1

Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double …

Clinical Infectious Diseases

Joseph E Levitt

Haley Hedlin

Sophie Duong

Di Lu

Justin Lee

...

2023/7/15

A Selective Leukotriene B4 Antagonist, Acebilustat, for Treatment of Outpatients With COVID-19 Disease: A Randomized, Double-blind, Placebo-controlled Phase 2 Trial

JE Levitt

H Hedlin

S Duong

D Lu

J Lee

...

2023/5

Oral hymecromone decreases hyaluronan in human study participants

The Journal of clinical investigation

Joelle I Rosser

Nadine Nagy

Riya Goel

Gernot Kaber

Sally Demirdjian

...

2022/5/2

Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area

Annals of Epidemiology

Christina P Lindan

Manisha Desai

Derek Boothroyd

Timothy Judson

Jenna Bollyky

...

2022/3/1

Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2

Diagnostic Microbiology and Infectious Disease

Shannon Richardson

Michael A Kohn

Jenna Bollyky

Julie Parsonnet

2022/11/1

Incidence and prevalence of coronavirus disease 2019 within a healthcare worker cohort during the first year of the severe acute respiratory syndrome coronavirus 2 pandemic

Clinical Infectious Diseases

Sarah B Doernberg

Marisa Holubar

Vivek Jain

Yingjie Weng

Di Lu

...

2022/11/1

Successful recruitment of monolingual Spanish speaking Latinos to university phase II and III outpatient COVID-19 clinical treatment trials in Northern California

Contemporary Clinical Trials

Vivian Levy

Ruth Yanes Bengoa

Priscilla Padilla Romero

Jenna Bollyky

Upinder Singh

2022/9/1

Healthcare personnel knowledge, motivations, concerns and intentions regarding COVID-19 vaccines: A cross-sectional survey

medRxiv

Vivek Jain

Sarah B Doernberg

Marisa Holubar

Beatrice Huang

Carina Marquez

...

2021/2/23

Race-ethnicity and COVID-19 vaccination beliefs and intentions: a cross-sectional study among the general population in the San Francisco Bay Area

Vaccines

Yingjie Weng

Di Lu

Jenna Bollyky

Vivek Jain

Manisha Desai

...

2021/11/29

High Completion of COVID-19 Vaccination Among Health Care Workers Despite Initial Self-Reported Vaccine Reluctance

Open Forum Infectious Diseases

Vivek Jain

Sarah B Doernberg

Marisa Holubar

Beatrice Huang

Jenna Bollyky

...

2021/10/1

Race-ethnicity and Perceptional Determinants of COVID-19 Vaccination Intentions: A Cross-sectional Study Among Health Workers and the General Population in the San Francisco …

medRxiv

Yingjie Weng

Di Lu

Jenna Bollyky

Vivek Jain

Manisha Desai

...

2021/4/29

XSL• FO

JMIR

Shelley Rottenberg

Allison Williams

2022

See List of Professors in Jenna Bollyky, MD University(Stanford University)